Clinical Research

Clinical research is fundamental to Sonex Health’s mission to deliver physicians innovative therapies that reduce invasiveness, improve safety, and reduce the cost of care.

Ultrasound-Guided Carpal Tunnel Release

Ultrasound-guided carpal tunnel release (UGCTR) was initially described by Nakamichi in 1997.10, 11 Since then, over 20 peer-reviewed publications have reported clinical results on over 2,800 unique hands (2,100 unique patients) with UGCTR using UltraGuideCTR.12-22, 30-39 The collective clinical success rate is over 95%, with these publications consistently documenting across multiple study designs and sites of service the safety and effectiveness of UGCTR, an excellent safety profile, and the ability to perform the procedure in the clinic setting. 12-22, 30-39

Clinical Experience

The first ultrasound-guided carpal tunnel release using UltraGuideCTRTM was performed in February 2017.

  • ✓
    Over 55,000 procedures completed including many simultaneous bilateral releases12-22, 30-39
  • ✓
    Procedures performed in the ASC, OR and clinic setting – most procedures performed using only local anesthesia/WALANT technique12-15, 17, 19-22, 30-33
  • ✓
    Post-operative discomfort typically managed with acetaminophen or NSAIDs as necessary12, 13-15, 17-22
  • ✓
    Statistically and clinically significant improvements in patient-reported outcome measures as early as 1-2 weeks and sustained at up to 6 years post-procedure12, 13, 15, 16, 18, 19, 21, 22, 30-34
  • ✓
    Most patients can return to work in 3-5 days12, 16, 19, 20, 32
UltraGuideCTR under real-time ultrasound showing carpal tunnel anatomy

Ultrasound-Guided Carpal Tunnel Release with UltraGuideCTR Clinical Summary

Ultrasound-Guided Carpal Tunnel Release with UltraGuideCTR™:
Clinical Summary